Gideon Argov
MANAGING PARTNER AND CO-FOUNDER @ New Era Capital Partners
Gideon Argov is a Series A investor at New Era Capital Partners focused on Artificial Intelligence and Sales. Gideon is also an Advisory Director of Berkshire Partners, an investment firm based in Boston. From 2004 to 2012 he was President and CEO of Entegris, a global supplier of products used in the production of high technology components and substrates. From 2001 to 2004 he was a Managing Director of Parthenon Capital, a private equity partnershipbased in Boston. From 1991 to 2000 he was Chairman, President and CEO of Kollmorgen Corporation, a supplier of high-performance electronic motion control products. Gideon is a serial angel investor in Israeli technology companies and served as the chairman of Fundtech and Servotronix.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Gideon Argov invests in
Stages Gideon Argov invests in
Countries Gideon Argov invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Artificial Intelligence 2 (50%)
- Sales 1 (25%)
- Genetics 1 (25%)
- Internet 1 (25%)
- Health Care 1 (25%)
Stage
- Series A 1 (25%)
- Series D 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- United States 2 (50%)
- Israel 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AUI (Augmented Intelligence)
|
Controllable AI Agents | $20M / Venture - Series Unknown / Nov 02, 2025 | |
aiola
|
Aiola’s mission is to bridge the gap between Human Intelligence and artificial intelligence while connecting the “AI promise” for the masses. By making AI accessible to everyone, we empower sales professionals and frontline employees with real-time, user-friendly, HUMINT-Driven business insights and intelligence on-the-go. | $25M / Series A / Jul 09, 2025 | |
Variantyx
|
Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditionalstep-wise, reiterative genetic testing. | $36M / Series D / Apr 26, 2024 | |
|
aiola
|
Aiola’s mission is to bridge the gap between Human Intelligence and artificial intelligence while connecting the “AI promise” for the masses. By making AI accessible to everyone, we empower sales professionals and frontline employees with real-time, user-friendly, HUMINT-Driven business insights and intelligence on-the-go. | $25M / Series A / Jan 18, 2023 |
Co-Investors
About New Era Capital Partners
New Era Capital Partners is a venture capital firm that invests in technology-focused and global enterprises.
New Era Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Gideon Argov
MANAGING PARTNER AND CO-FOUNDER
|
|||
Ran Simha
Co-Founder & Managing director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Gideon Argov invest in?
Gideon Argov invests primarily in Artificial Intelligence, Sales and Genetics startups, most often at Series A and Series D stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Gideon Argov?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Gideon Argov last invest?
The most recent investment recorded for Gideon Argov closed in Nov 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
